AMFI - Registered Mutual Fund Distributor

Corona Remedies Limited IPO

Corona Remedies Limited IPO

₹ 14868 / 14 Shares Shares
Minimum Investment

Corona Remedies Limited IPO

Issues Price

₹1008-1062 per equity share

Corona Remedies Limited IPO

Open Date

08 Dec 2025

Close Date

10 Dec 2025

Lot Size

14

Min. Investment

₹ 14868

Issue Price

₹1008-1062

Listing Date

15 Dec 2025

Issues Size

61,71,101 shares(aggregating up to ₹655.37 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

14 Shares

Offered To Public

14 Shares

Corona Remedies Limited IPO

Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.

Founded In

2004

Managing Director

Dr. Kirtikumar Laxmidas Mehta

Parent Organization

Corona Remedies Limited IPO

Application Details of Corona Remedies Limited IPO.

Apply as Price Range Apply Upto
Retail (min) ₹1008-1062 ₹14,868
Retail(max) ₹1008-1062 ₹1,93,284
SHNI(min) ₹1008-1062 ₹2,08,152
SHNI(max) ₹1008-1062 ₹9,96,156
BHNI(min) ₹1008-1062 ₹10,11,024

For Corona Remedies Limited IPO, eligible investors can apply as Regular.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.7 Out of 5 (8392 Reviews)

Investing used to feel intimidating, but KSquare has simplified everything. Their SIP plans offer great flexibility and peace of mind. I recommend them to all my colleagues.

Rohan Malhotra

Rohan Malhotra

Sales Executive

Very few services feel as reliable as KSquare’s NRI Corner. Their consistent communication and legal clarity made my decisions easier.

Dev Mehta

Dev Mehta

Aerospace Engineer

I didn’t want to disturb my investments, and KSquare gave me the perfect option. I got the loan in no time.

Nikhil Rane

Nikhil Rane

Visual Designer

KSquare’s recommendations are on point. Their mutual fund picks are backed by solid research, and I’ve seen consistent returns over the past year.

Arvind Joshi

Arvind Joshi

Civil Contractor

I used to avoid NFOs due to uncertainty. KSquare’s clear data and investor tools changed my mind. Now, I feel fully informed and prepared.

Ankita Pillai

Ankita Pillai

Tour Operator

KSquare made the loan process so efficient that I didn’t feel stressed at all. Fantastic customer support as well.

Riya Bhattacharya

Riya Bhattacharya

Brand Consultant

I appreciated how KSquare simplified the NPS jargon. Everything was laid out clearly with ongoing support.

Manish Talreja

Manish Talreja

Sales Head

As someone new to investing, KSquare’s SIP guidance has been incredibly helpful. Their platform is user-friendly, and the support team answered all my questions patiently.

Neha Gupta

Neha Gupta

HR Specialist

What I like most about KSquare is the clarity and control I have over my investments. SIPs have never been easier to manage.

Nikhil Arora

Nikhil Arora

UX Designer

The pension solutions offered by KSquare are well-structured. I got real-time assistance and no sales pressure at all.

Saurabh Pratap

Saurabh Pratap

Creative Director

FAQ's

Frequenlty Asked Question

How is an NFO different from regular mutual fund schemes?

Unlike existing funds with track records, NFOs offer fresh investment opportunities, often at a face value of ₹10.

How does KSquare help in availing a loan against mutual funds?

KSquare simplifies the process by partnering with lenders and offering a smooth, digital journey from application to disbursal.

Is it safe to invest in NPS?

NPS is regulated by PFRDA and offers transparency, safety, and steady growth through professional fund managers.

How do I track my investments from overseas?

KSquare’s online dashboard lets NRIs monitor and manage portfolios 24/7, no matter where they are in the world.

What are mutual funds and how do they work?

Mutual funds pool money from many investors to invest in a diversified portfolio of stocks, bonds, or other assets managed by professionals.

Can I have multiple SIPs for different goals?

Yes, you can set up multiple SIPs with KSquare for various goals like retirement, education, or buying a home.

What fees or charges are involved in mutual fund investing?

Mutual funds may have expense ratios and exit loads. KSquare discloses all charges clearly before you invest.

Is SIP a good option for first-time investors?

Absolutely! SIPs are ideal for beginners due to their simplicity, flexibility, and potential for long-term wealth creation.

App Store

Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.